These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36004011)

  • 21. [Immune thrombocytopenia preceded by asymptomatic COVID-19 infection].
    Ochiai T; Ando J; Harada S; Hiki M; Ando M; Komatsu N
    Rinsho Ketsueki; 2021; 62(1):58-60. PubMed ID: 33551428
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and Safety of a New 10% Intravenous Immunoglobulin Product in Patients with Primary Immune Thrombocytopenia (ITP).
    Hong J; Bang SM; Mun YC; Yhim HY; Lee J; Lim HS; Oh D;
    J Korean Med Sci; 2018 May; 33(19):e142. PubMed ID: 29736158
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outcome and management in neonatal thrombocytopenia due to maternal idiopathic thrombocytopenic purpura.
    van der Lugt NM; van Kampen A; Walther FJ; Brand A; Lopriore E
    Vox Sang; 2013 Oct; 105(3):236-43. PubMed ID: 23782272
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolated thrombocytopenia in patients infected with HIV: treatment with intravenous gammaglobulin.
    Bussel JB; Haimi JS
    Am J Hematol; 1988 Jun; 28(2):79-84. PubMed ID: 2456012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical Implication of the Effect of the Production of Neutralizing Antibodies Against SARS-Cov-2 for Chronic Immune Thrombocytopenia Flare-Up Associated with COVID-19 Infection: A Case Report and the Review of Literature.
    Maekura C; Muramatsu A; Nagata H; Okamoto H; Onishi A; Kato D; Isa R; Fujino T; Tsukamoto T; Mizutani S; Shimura Y; Kobayashi T; Okumura K; Inaba T; Nukui Y; Kuroda J
    Infect Drug Resist; 2022; 15():2723-2728. PubMed ID: 35668857
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immune Thrombocytopenic Purpura (ITP) Following Natural COVID-19 Infection.
    Santhosh S; Malik B; Kalantary A; Kunadi A
    Cureus; 2022 Jul; 14(7):e26582. PubMed ID: 35815306
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of sarcoidosis and immune thrombocytopenia: presentation and outcome in a series of 20 patients.
    Mahévas M; Chiche L; Uzunhan Y; Khellaf M; Morin AS; Le Guenno G; Péronne V; Affo L; Lidove O; Boutboul D; Dion G; Ducroix JP; Papo T; Pacheco Y; Schleinitz N; Michel M; Godeau B; Valeyre D
    Medicine (Baltimore); 2011 Jul; 90(4):269-278. PubMed ID: 21694642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CLINICAL RELEVANCE OF EXTENDED PLATELET INDICES IN THE DIAGNOSIS OF IMMUNE THROMBOCYTOPENIA.
    Arshad A; Mukry SN; Shamsi TS
    Acta Clin Croat; 2021 Dec; 60(4):665-674. PubMed ID: 35734488
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment with eltrombopag of severe immune thrombocytopenia and hemolytic anemia associated with COVID-19 pneumonia: a case report.
    Gruden G; Beggiato E; Camerino E; Capriotti S; Canepa S; Scandella M; Avolio M; Pittalunga F; Barutta F; Durazzo M
    Ther Adv Hematol; 2021; 12():20406207211011353. PubMed ID: 33995989
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune thrombocytopenia of childhood responsive to tonsillectomy in the setting of chronic tonsillitis: A case report and literature review.
    Thompson RW; Gungor A
    Am J Otolaryngol; 2017; 38(5):639-641. PubMed ID: 28648251
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dental procedures in 24 patients with chronic immune thrombocytopenia in prospective clinical studies of eltrombopag.
    Tarantino MD; Fogarty PF; Shah P; Brainsky A
    Platelets; 2015; 26(1):93-6. PubMed ID: 24433306
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary Immune Thrombocytopenia Associated With Asymptomatic COVID-19 Successfully Managed With Intravenous Immunoglobulin and Glucocorticoids.
    Ayesh H; Beran A; Mhanna M; Hejeebu S
    Cureus; 2021 May; 13(5):e15153. PubMed ID: 34178488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COVID-19 associated with immune thrombocytopenia: a systematic review and meta-analysis.
    Alharbi MG; Alanazi N; Yousef A; Alanazi N; Alotaibi B; Aljurf M; El Fakih R
    Expert Rev Hematol; 2022 Feb; 15(2):157-166. PubMed ID: 35025706
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of predictive factors for response to intravenous immunoglobulin treatment in children with immune thrombocytopenia.
    Morimoto Y; Yoshida N; Kawashima N; Matsumoto K; Kato K
    Int J Hematol; 2014; 99(5):597-602. PubMed ID: 24573984
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
    Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
    BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Thrombocytopenia Exacerbation After COVID-19 Vaccination in a Young Woman.
    Fujita M; Ureshino H; Sugihara A; Nishioka A; Kimura S
    Cureus; 2021 Sep; 13(9):e17942. PubMed ID: 34660131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 induced immune thrombocytopenic purpura: case report.
    Ashraf S; Alsharedi M
    Stem Cell Investig; 2021; 8():14. PubMed ID: 34386543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Secondary Immune Thrombocytopenic Purpura Triggered by COVID-19.
    Watts A; Raj K; Gogia P; Toquica Gahona CC; Porcelli M
    Cureus; 2021 Apr; 13(4):e14505. PubMed ID: 34007758
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical course and prognostic factors of childhood immune thrombocytopenia: single center experience of 10 years.
    Jung JY; O AR; Kim JK; Park M
    Korean J Pediatr; 2016 Aug; 59(8):335-40. PubMed ID: 27610182
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.